The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

  • ‘Fluffy’ crab from Australia that wears sea sponge like a hat named after Darwin’s ship

  • US Fed meeting to dollar index: Top 5 triggers for yellow metal next week

  • Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO William J. Peters Sells 18,386 Shares

  • Insider Selling: Taysha Gene Therapies, Inc. (NASDAQ:TSHA) CMO Sells 12,324 Shares of Stock

Stock Shares
Home›Stock Shares›Rakesh Jhunjhunwala favourite stock: Titan shares falls 15% so far in 2022; should you buy, hold or sell?

Rakesh Jhunjhunwala favourite stock: Titan shares falls 15% so far in 2022; should you buy, hold or sell?

By Megan
June 9, 2022
4
0
Share:

Rakesh Jhunjhunwala portfolio stock Titan Company has tanked 15 per cent so far in 2022 amid high volatility on Dalal Street. Titan shares have even underperformed benchmark NSE Nifty 50 which has tumbled over 7 per cent so far this year. According to the latest shareholding pattern, Rakesh Jhunjhunwala owns 3.5 crore shares while his wife Rekha holds 95 lakh shares of Titan. The couple collectively held 5.05% stake in the company till quarter ended March 2022. Despite the correction, several brokerages remain bullish on the Tata group company stock. Titan shares were quoting at Rs 2,136, down 0.4 per cent on NSE intraday.

Long-term structure still bullish

Santosh Meena, Head of Research, Swastika Investmart Ltd. said, “Titan is trying to create a base around the 2,050 level after a healthy correction, however 2,300-2,350 is a critical resistance area as a cluster of key moving averages. Therefore, 2,050-2,350 is a well-defined trading band and if it manages to take out the 2,350 level, we can expect fresh bullish momentum while if it slips below the 2,050 level, then 1,900 will be the next sacrosanct support level. Existing investors should hold this stock as the long-term structure is still bullish whereas one can start to accumulate from current levels.”

Purchase at Rs 2,140 with a stop loss of Rs 2,030

“Titan’s stock price has dropped 15% so far in 2022, compared to a 7% drop in the benchmark Nifty index. Given its market share of less than 10% and the continuous problems of its unorganised and organised competitors, TITAN has a long expansion runway. It has unrivalled medium-to-long-term earnings growth visibility. Technically, the stock has been moving in an upward channel since March 2022 and is currently trading near the lower band of the channel, indicating a buying opportunity. Apart from that, Titan is trading above its 100 and 200 SMAs after a 15% pullback, indicating stock strength. Stocks can be purchased at a price of 2,140 with a stop loss of 2,030 with a target price of Rs 2,600,” said Vijay Dhanotiya – Lead Technical Research at CapitalVia Global Research.

52-week high, 52-week low: Oil India, Hindustan Motors among 47 BSE stocks to hit fresh highs; LIC at new low

Dividend

Hindustan Unilever, HDFC AMC, Tata Steel, Asian Paints among stocks that go ex-dividend soon; check full list

LIC, LIC share price

LIC share price at new record low, falls for 8th straight day, dives 22% from IPO price; buy, sell, hold?

ITC stock

ITC stock price may rally 30% in 18 months, dividend extra; brokerage firm initiates coverage at ‘strong buy’

Should you buy, hold or sell Titan Company shares?

ICICI Direct in a report last month said, “We continue to remain structurally positive on the stock as high growth visibility justifies premium valuations and maintain a BUY on the stock.” The brokerage values Titan at Rs 2,725

Axis Capital upgraded the stock to ‘Reduce’ from a ‘Sell’ rating last month with a target price of Rs 2,050. The brokerage said that the recent correction has reduced Titan’s premium to its historical P/E band.

Sharekhan by BNP Paribas also has a buy call on Titan Company Ltd. with a target price of Rs 2,900.0.

Titan Company shares remain Motilal Oswal’s top pick in the largecap consumption space in India, with strong earnings growth visibility and compounding ~20% for an elongated period of time. “In the Jewellery industry, which is organising at a rapid pace, Titan is clearly at the vanguard among organised players in leading this growth. Its runway for growth is long, with a market share of just 6%,” the brokerage said in its report last month. It maintained a ‘buy’ rating on the stock with a target price of Rs 2,900, implying 39% upside.

(The stock recommendations in this story are by the respective research analysts and brokerage firms. FinancialExpress.com does not bear any responsibility for their investment advice. Capital markets investments are subject to rules and regulations. Please consult your investment advisor before investing.)

Source link

TagsRakesh JhunjhunwalaRakesh Jhunjhunwala portfolio stocktitan company stocktitan share price nsetitan share target pricetitan shares
Previous Article

Live news updates: NatWest chief sees ‘strong’ ...

Next Article

Investing in health should be among our ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Stock Shares

    Rakesh Jhunjhunwala Portfolio Sees A Hit Of ₹540 Crore In One Month From These 2 Stocks

    May 30, 2022
    By Megan
  • Stock Shares

    Rakesh Jhunjhunwala portfolio stock Nazara Tech fixes record date for bonus shares issue

    June 15, 2022
    By Megan
  • Stock Shares

    Rakesh Jhunjhunwala portfolio stock hits 52-week low. Should you accumulate?

    June 28, 2022
    By Megan
  • Stock Shares

    These 3 stocks pull down Rakesh Jhunjhunwala’s net worth by ₹900 crore in 15 minutes

    June 17, 2022
    By Megan
  • Stock Shares

    Rakesh Jhunjhunwala Sells 25 Lakh Delta Corp Shares; Stock Tanks Over 4%

    June 1, 2022
    By Megan
  • Stock Shares

    Rakesh Jhunjhunwala Portfolio: Experts Give ‘buy’ Tag To This Tata Stock

    June 3, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Investment

    Foreign investment in U.S. farmland may be a national security issue, according to expert | National

  • Investment

    Morgan Stanley Investment Head Sees Hidden Inflation Threat In Dollars And Commodities

  • Australian Economy

    Vietnam, Australia promote trade, investment partnership | Business

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • July 3, 2022

    NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

  • July 3, 2022

    ‘Fluffy’ crab from Australia that wears sea sponge like a hat named after Darwin’s ship

  • July 3, 2022

    US Fed meeting to dollar index: Top 5 triggers for yellow metal next week

  • July 3, 2022

    Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO William J. Peters Sells 18,386 Shares

  • July 3, 2022

    Insider Selling: Taysha Gene Therapies, Inc. (NASDAQ:TSHA) CMO Sells 12,324 Shares of Stock

Best Reviews

Latest News

Investment

NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

28 Mar Nearly two years after the Nigerian National Petroleum Company (NNPC) Limited announced plans to reduce the cost of oil production to about $10 per barrel, this effort has ...
  • ‘Fluffy’ crab from Australia that wears sea sponge like a hat named after Darwin’s ship

    By Megan
    July 3, 2022
  • US Fed meeting to dollar index: Top 5 triggers for yellow metal next week

    By Megan
    July 3, 2022
  • Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO William J. Peters Sells 18,386 Shares

    By Megan
    July 3, 2022
  • Insider Selling: Taysha Gene Therapies, Inc. (NASDAQ:TSHA) CMO Sells 12,324 Shares of Stock

    By Megan
    July 3, 2022
  • Recent

  • Popular

  • Comments

  • NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

    By Megan
    July 3, 2022
  • ‘Fluffy’ crab from Australia that wears sea sponge like a hat named after Darwin’s ship

    By Megan
    July 3, 2022
  • US Fed meeting to dollar index: Top 5 triggers for yellow metal next week

    By Megan
    July 3, 2022
  • Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO William J. Peters Sells 18,386 Shares

    By Megan
    July 3, 2022
  • NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

    By Megan
    July 3, 2022
  • Australian economy survived Covid better than most but recovery could slow, OECD says | Australian ...

    By Megan
    September 14, 2021
  • The Best Online Brokers, According to 5 Financial Experts

    By Megan
    September 14, 2021
  • Is Disaster Looming for Australia’s Economy?

    By Megan
    September 29, 2021

Trending News

  • Investment

    NIPCO leverages on PIA, to increase investment in petroleum sector | The Guardian Nigeria News

    28 Mar Nearly two years after the Nigerian National Petroleum Company (NNPC) Limited announced plans to reduce the cost of oil production to about $10 per barrel, this effort has ...
  • Australian Economy

    ‘Fluffy’ crab from Australia that wears sea sponge like a hat named after Darwin’s ship

    New Delhi: A “fluffy” crab that uses a sea sponge like a hat to protect itself, discovered off the coast of Australia, has been named after a ship that English ...
  • Gold and Precious Metals

    US Fed meeting to dollar index: Top 5 triggers for yellow metal next week

    Gold prices remained trapped in a range this week, wherein there was a divergence in domestic and international gold prices. The precious metal witnessed a decline in the international markets, ...
  • Stock Shares

    Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO William J. Peters Sells 18,386 Shares

    Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) CFO William J. Peters sold 18,386 shares of the business’s stock in a transaction on Thursday, June 30th. The shares were sold at ...
  • Stock Shares

    Insider Selling: Taysha Gene Therapies, Inc. (NASDAQ:TSHA) CMO Sells 12,324 Shares of Stock

    Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Rating) CMO Suyash Prasad sold 12,324 shares of the firm’s stock in a transaction dated Wednesday, June 29th. The stock was sold at ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.